Thermo Fisher Announces FDA-Compliant Spectrophotometer
Its NanoDrop One PC Control + Security Suite Software for the NanoDrop One/OneC can now be used in compliance with FDA regulations.
Thermo Fisher Scientific announced its NanoDrop One PC Control + Security Suite Software for the NanoDrop One/OneC, an instrument that identifies contaminants in nucleic acid and protein samples, can now be used in compliance with FDA’s Title 21 Code of Federal Regulations Part 11, which covers the security of electronic records and signatures to guarantee they are reliable alternatives for paper records and handwritten signatures.
According to a June 8, 2020 press release, the security suite met FDA’s requirements because of its ability to provide administrative control over user accounts, utilize an audit trail for user integrity, and use electronic signatures.
"Regulated pharma and biotech labs can now take full advantage of our powerful NanoDrop One/OneC instruments," said Jim Metzger, general manager, UV/Vis spectroscopy at Thermo Fisher Scientific, in the press release. "NanoDrop One/OneC is the market-leading microvolume spectrophotometer for DNA, RNA, and protein quantification, and we're pleased to extend these critical instruments to labs where compliance is a requirement."
Source: Thermo Fisher Scientific
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
